Li Minrui, Zhang Shenghong, Gu Fang, Xiao Weiwei, Yao Jiayan, Chao Kang, Chen Minhu, Li Juan, Zhong Bihui
Division of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University Guangzhou 510080, P.R. China.
Division of Radiation Oncology, Cancer Center of Sun Yat-sen University Guangzhou 510080, P.R. China ; State Key Laboratory of Oncology in South China Guangzhou 510080, P.R. China.
Int J Clin Exp Pathol. 2014 Apr 15;7(5):2718-28. eCollection 2014.
Primary gastrointestinal lymphoma (PGIL) is a kind of relatively rare cancer and easily misdiagnosed due to its unspecific signs in digestive tract. Data including 216 patients histologically diagnosed as PGIL between January 1991 and October 2012 from The First Affiliated Hospital of Sun Yat-sen University were reviewed. This study was to investigate the clinicopathological features and prognosis, and make the comparison between the different sites of PGIL. Abdominal pain (75.9%) was the most frequent symptom and intermediate-grade lymphoma (53.7%) presented as the most common histological type. Intestine (55.1%) was the most common site involved, followed by stomach (38.5%), both intestine and stomach (6.4%). PGIL of different original site showed distinguished clinicopathological characteristics that patients in Stomach and GI group were older than Intestine group (Mean age: 54 and 53 vs. 43 years, p<0.001); diarrhea, B symptom, abdominal mass and complication occurred more in intestine group. Histologically, high-grade lymphoma (especially T-cell type) almost located in Intestine group (82.5%). Five-year overall survival (OS) and event-free survival (EFS) for all PGIL patients were 56.4% and 49.3%, respectively. Stomach group had better OS (72.3%) and EFS (48.4%) than Intestine group (43.1% and 23.6% respectively), but it lost the significance in the multivariate analysis. Univariate and multivariate analysis revealed that performance status, lactate dehydrogenase (LDH) level and histological type were independent prognostic factors for PGIL.
原发性胃肠道淋巴瘤(PGIL)是一种相对罕见的癌症,由于其在消化道的症状不具特异性,容易被误诊。回顾了1991年1月至2012年10月间中山大学附属第一医院216例经组织学诊断为PGIL的患者的数据。本研究旨在探讨其临床病理特征及预后,并对PGIL不同发病部位进行比较。腹痛(75.9%)是最常见的症状,中等分化淋巴瘤(53.7%)是最常见的组织学类型。肠道(55.1%)是最常受累的部位,其次是胃(38.5%),肠道和胃均受累(6.4%)。不同原发部位的PGIL表现出不同的临床病理特征,胃和胃肠道组患者比肠道组患者年龄更大(平均年龄:54岁和53岁对43岁,p<0.001);腹泻、B症状、腹部肿块及并发症在肠道组更为多见。组织学上,高度恶性淋巴瘤(尤其是T细胞型)几乎都位于肠道组(82.5%)。所有PGIL患者的5年总生存率(OS)和无事件生存率(EFS)分别为56.4%和49.3%。胃组的OS(72.3%)和EFS(48.4%)优于肠道组(分别为43.1%和23.6%),但在多因素分析中失去了显著性。单因素和多因素分析显示,体能状态、乳酸脱氢酶(LDH)水平和组织学类型是PGIL的独立预后因素。